Extracellular Vesicles As Mediators of Resistance to EGFR-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Preclinical Models

• M. Pérez-Capó,
• D. de Miguel-Pérez,
• A. Obrador-Hevia,
• T. Sen,
• C. Rolfo

Affiliations

M. Pérez-Capó

Health Research Institute of the Balearic Islands, Palma De Mallorca, Spain

D. de Miguel-Pérez

Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, USA

A. Obrador-Hevia

Health Research Institute of the Balearic Islands, Palma De Mallorca, Spain; Molecular Diagnosis Unit, Son Espases University Hospital, Palma de Mallorca, Spain

T. Sen

Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, USA; Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA

C. Rolfo

Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, USA